pharmaceutical investing Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
medical device investing Arch Therapeutics to Provide Corporate Update at the Maxim Group – Haitong Securities Healthcare Investor and Partnering Conference
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds
QIMC Announces Closing of $17.3 Million Bought Deal Offering, Including Full Exercise of Underwriter's Over-Allotment Option
New Found Gold Closes Bought Deal Financing Including Full Exercise of Underwriters' Over-Allotment Option for Gross Proceeds of $115M
Couloir Capital Is Pleased to Announce That It Has Initiated Research Coverage on Pinnacle Silver and Gold
